Page tree

Date

20200401

Document Version

0.1

Release Status

ALPHA

  



© 2024 International Health Terminology Standards Development Organisation.  All rights reserved.  SNOMED CT® was originally created by the College of American Pathologists.

This document forms part of the SNOMED CT® MedDRA Map package distributed by International Health Terminology Standards Development Organisation, trading as SNOMED International, and is subject to the SNOMED CT® Affiliate License, details of which may be found at https://www.snomed.org/snomed-ct/get-snomed

No part of this document may be reproduced or transmitted in any form or by any means, or stored in any kind of retrieval system, except by an Affiliate of SNOMED International in accordance with the SNOMED CT® Affiliate License. Any modification of this document (including without limitation the removal or modification of this notice) is prohibited without the express written permission of SNOMED International.

Any copy of this document that is not obtained directly from SNOMED International [or a Member of SNOMED International] is not controlled by SNOMED International, and may have been modified and may be out of date. Any recipient of this document who has received it by other means is encouraged to obtain a copy directly from SNOMED International [or a Member of SNOMED International. Details of the Members of SNOMED International may be found at http://www.snomed.org/members/].

Access within SNOMED International member countries is provided by the Member National Release Centre in each country, via the relevant Member webpage.  Affiliates of SNOMED International in non-member countries can access the table through their MLDS (Member Licensing & Distribution Service) account.  


Page At A Glance

1. Introduction

The SNOMED CT terminology provides a common language that enables a consistent way of indexing, storing, retrieving, and aggregating clinical data across specialties and sites of care. The International Health Terminology Standards Development Organisation (IHTSDO®) maintains the SNOMED CT technical design, the content architecture, the SNOMED CT content (including the concepts table, the descriptions table, the relationships table, a history table and mappings), and related technical documentation. 

This document is intended to give a brief description, background context and explanatory notes on the SNOMED CT International/ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) work through the EU funded WEB RADR 2 project and the resulting Release package and the resulting SNOMED CT/MedDRA maps, which are being published as an Alpha release at this time with intention to publish a production release in April 2021. This document covers the background to the collaboration between SNOMED International and ICH, through the MedDRA MSSO, as part of the project and goes on to cover the consequent release artefacts. It is not a detailed technical document of SNOMED CT, MedDRA or the SNOMED CT International/ MedDRA release. Nor does it seek to provide an editorial policy for this content though does provide details of the Mapping conventions applied.

At this time, SNOMED International and ICH are seeking feedback on the Alpha version of the 2 Maps, and a Test/Review protocol has been produced as part of this package which indicates some of the areas on which feedback is invited. The Test/Review period ends on 30 September 2020, after which work will be undertaken to update the Maps in line with January 2021 SNOMED CT International Release and MedDRA September 2020 release. A report of the feedback will be made available. Please note that the Maps will NOT be extended beyond current scope for the Production release. The Production release in April 2021 will be available to licensed users of either SNOMED CT of MedDRA.

This ALPHA release package is distributed for evaluation purposes only.  It must not be used in production clinical systems or in clinical settings, or distributed to Affiliate Licensees or any third parties.   

2. Audience for this document

This document should be read by all those (SNOMED International National Release Centers, vendors of electronic health records, terminology developers, Regulators and Pharmaceutical Industry) with an interest in the usage of this content in SNOMED CT and its linkage with MedDRA i.e. the SNOMED CT to MedDRA and MedDRA to SNOMED CT maps based on a priority set of MedDRA. 

3. Background

In 2018, SNOMED International and ICH joined the WEB-RADR 2 project, funded by Innovative Medicines Initiative (IMI). SNOMED International and ICH led the effort to develop 2 maps between SNOMED CT and MedDRA. A specific work package was devoted to this purpose and included participants from regulatory authorities and industry as well as SNOMED International and MedDRA MSSO. The project delivered the following:

  • 2 maps (MedDRA to SNOMED CT and SNOMED CT to MedDRA) of frequently-used pharmacovigilance MedDRA terms that were identified from databases from the UK’s Medicines & Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA). This subset represents the high value terms to support interoperability between the terminologies.
  • A set of Mapping conventions that were drafted as part of a pilot set and updated for the main body of work.
  • A small number of content additions to SNOMED CT in support of the MedDRA high value terms as defined by scope and editorial rules of SNOMED CT.

The Use cases of the project were defined as:

SNOMED CT to MedDRA map:

Key pharmacovigilance concepts when coded in SNOMED CT in an electronic health record could be converted to MedDRA for the purpose of adverse event reporting to regulatory authorities or for the purposes of epidemiological research. 

MedDRA to SNOMED CT map:

Clinical care decision support: Terms coded in MedDRA representing adverse events, warnings, and other regulatory information in product labeling could be converted into SNOMED CT so that the information is integrated into the electronic health record or decision support system to be visible to healthcare professionals when prescribing, dispensing, or administering the product to patients.

PROCESS:

A big thank you is offered to all contributors to the Maps.

The mapping work was undertaken using dual independent review by mappers who were Consortium members of the WEB RADR 2 project and experts in either SNOMED CT or MedDRA. Quality Assurance, based on the mapping conventions, was managed as part of the process by SNOMED International and MedDRA MSSO (on behalf of ICH) and technical assurance reports provided weekly using the Mapping tool used by all participants.  The Mapping Conventions used are provided for information as part of this package.

In parallel to the mapping work, the operational aspects have been worked on to agree activities and processes to enable the 2 Maps to move in to Production in April 2021 and from there to be maintained and updated according to changes within the 2 terminologies and Use Case based requirements for additions to the Maps - thus meeting one of the key requirements of IMI to produce products in the project that are sustainable over time.

4. Scope and Purpose of the collaborative work going forward. 

The scope of the SNOMED International and ICH work through the WEB RADR 2 project has been outlined above, and the 2 organizations are now in the process of formalizing the next steps in a Collaboration agreement which ensures that the 2 Maps are updated, after feedback from the Alpha release, to form the Production release in April 2021. 

Under the terms of the Collaboration agreement between SNOMED International and the ICH, the Maps will be issued annually by both SNOMED International in RF2 format and  MedDRA MSSO in spreadsheet format. Documented quality assurance processes will ensure both formats are the same and supporting materials are produced jointly. In addition, criteria for extending the Maps will be agreed and managed through agreed processes to ensure that the products meet the needs of the different stakeholder groups as defined by the Use Cases.

5. Release content

5.1. Overview

The MedDRA derivative content is released under a project-specific module (816211006) with component identifiers that are within the main IHTSDO (International Release) namespace. Placement in the SNOMED hierarchy is based on existing MedDRA groupings ('collective terms'). 

5.2. Content detail

The content is based on a high value set of MedDRA terms identified as part of the WEB RADR 2 project, taking data from European Medicines Agency and  UK’s Medicines & Healthcare products Regulatory Agency (MHRA) - just under 7500 were evaluated for being in scope of SNOMED CT. Approximately 100 new concepts have been added to SNOMED CT as a consequence of this work.

5.3. Dependent Content

The January 2019 SNOMED CT International Edition is the baseline for the April 2020 SNOMED CT MedDRA Map package, and therefore all filenames and record have been assigned the value of 20190131 in the effectiveTime field. The Maps use MedDRA version 21.1, released September 2018.

6. Obtaining the Alpha release

Access within IHTSDO member countries is provided by the Member National Release Centre in each country, via the relevant Member page. Affiliates of IHTSDO in non-member countries can access the table through their Member Licensing and Distribution Service (MLDS) account. Please contact info@snomed.org for more information if required. 

The  spreadsheet versions of the Maps can be obtained from MedDRA MSSO at mssohelp@meddra.org

Reviewers of the Maps should have a licence for either MedDRA and SNOMED CT.

If you’re having any problems getting hold of the SNOMED CT MedDRA Simple Map Package, please contact info@snomed.org

7. Feedback

Feedback should be sent jointly to info@snomed.org and mssohelp@meddra.org. The Test/Review protocol document (see section 8. Supporting Documentation below) provides guidance on the type of feedback the two parties would like to receive. In addition, the Mapping Conventions document (again in section 8 below) should form part of the feedback.

Feedback should be sent as soon as possible, but no later than the 30th September 2020.

Please download and use the following form to provide feedback to both parties:

8. Supporting documentation

Please visit the following web pages for the supporting documentation:

9. Technical Notes

9.1. RF2 package format

The RF2 package convention dictates that it contains all relevant files, regardless of whether or not there is content to be included in each particular release.  Therefore, the package contains a mixture of files which contain both header rows and content data, and also files that are intentionally left blank (including only a header record).  The reason that these files are not removed from the package is to draw a clear distinction between:

  1. ...files that have been deprecated (and therefore removed from the package completely), due to the content no longer being relevant to RF2 in this or future releases, and 
  2. ...files that just happen to contain no data in this particular release (and are therefore included in the package but left blank, with only a header record), but are still relevant to RF2, and could therefore potentially contain data in future releases.

This allows users to easily distinguish between files that have purposefully been removed or not, as otherwise if files in option 2 above were left out of the package it could be interpreted as an error, rather than an intentional lack of content in that release.

9.2. RF2 map files

Both SNOMED CT to MedDRA and MedDRA to SNOMED CT simple map files are contained in the same package, and therefore are linked by the same moduleID (816211006).

However, they can be individually identified by their relative refset ID's, as follows:

  • SNOMED CT to MedDRA = 816210007
  • MedDRA to SNOMED CT = 816209002


Approvals


Final Version

Date

Approver

Comments

0.1

 

Jane Millar
0.1

 

Monica Harry
0.1
Donna Morgan





Download .pdf here:









Draft Amendment History


Version

Date

Editor

Comments

0.1

11/02/2020 

Andrew AtkinsonInitial draft

03/03/2020Jane MillarUpdates

09/03/2020Donna MorganComments

09/03/2020Andrew AtkinsonFixes to format and technical notes added



  • No labels